Literature DB >> 15825160

Retromolar trigone squamous cell carcinoma treated with radiotherapy alone or combined with surgery.

William M Mendenhall1, Christopher G Morris, Robert J Amdur, John W Werning, Douglas B Villaret.   

Abstract

BACKGROUND: Treatment outcomes were analyzed for retromolar trigone squamous cell carcinoma.
METHODS: Between June 1966 and August 2003, 99 patients were treated with radiotherapy alone (35 patients) or radiotherapy combined with surgery (64 patients). Followup ranged from 0.2 to 23.8 years (median, 3.3 yrs). All living patients had followup for at least 1 year.
RESULTS: The 5-year local-regional control rates after definitive radiotherapy versus surgery and radiotherapy were as follows: Stages I-III, 51% and 87%; Stage IV, 42% and 62%; and overall, 48% and 71%, respectively. The 5-year cause-specific survival rates after definitive radiotherapy compared with surgery and radiotherapy were as follows: Stages I-III, 56% and 83%; Stage IV, 50% and 61%; and overall, 52% and 69%, respectively. Multivariate analyses revealed that the likelihood of cure was better with surgery and radiotherapy compared with definitive radiotherapy.
CONCLUSIONS: The likelihood of cure after treatment for retromolar trigone squamous cell carcinoma was influenced by the extent of disease and treatment. Patients treated with surgery and radiotherapy had a better outcome than those treated with radiotherapy alone.

Entities:  

Mesh:

Year:  2005        PMID: 15825160     DOI: 10.1002/cncr.21038

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma.

Authors:  Ken Omura
Journal:  Int J Clin Oncol       Date:  2014-04-01       Impact factor: 3.402

2.  Variation in treatment and outcome in the early stage oral cavity squamous cell carcinoma.

Authors:  Darragh S Gogarty; Paul Lennon; Sandra Deady; J Barry O'Sullivan; Orla McArdle; Mary Leader; Patrick Sheahan; James Paul O'Neill
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-23       Impact factor: 2.503

3.  Treatment Outcomes for Primary Retromolar Trigone Carcinoma: A Single Institution Experience.

Authors:  Uygar Levent Demir; Halide Öztürk Yanaşma
Journal:  Turk Arch Otorhinolaryngol       Date:  2020-06-01

4.  Treatment Outcomes of Rare Retromolar Trigone Squamous Cell Carcinoma Using Combined Modalities.

Authors:  Muhammad Faisal; Taskheer Abbas; Usman Khaleeq; Mohammad Adeel; Abdul Wahid Anwer; Raza Hussain; Arif Jamshed
Journal:  Cureus       Date:  2017-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.